Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2020 Earnings Conference Call March 4, 2021 5:00 PM ET Company Participants Mark Namaroff - Executive Director of IR and Corporate Communications Cheryl Blanchard - President and CEO Michael Levitz - EVP, CFO and Treasurer Conference Call Participants Jim Sidoti - Sidoti & Company Mike Petusky - Barrington Research Operator Good evening, ladies and gentlemen, and welcome to Anika's Fourth Quarter and Full Year 2020 Earnings Conference Call. As a reminder, all partic ...

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2020 Earnings Conference Call November 4, 2020 5:00 PM ET Company Participants Kristen Galfetti - IR Cheryl Blanchard - President and CEO Michael Levitz - EVP, CFO and Treasurer Conference Call Participants Jim Sidoti - Sidoti Mike Petusky - Barrington Research Operator Good evening, ladies and gentlemen, and welcome to Anika's Third Quarter 2020 Earnings Conference Call. [Operator Instructions] I will now turn the conference over to Kristen Galfetti, Executive Dire ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-21326 Anika Therapeutics, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3145961 (State or Other Jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-21326 Anika Therapeutics, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3145961 (State or Other Jurisdiction of (I. ...

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Kristen Galfetti - Investor Relations Cheryl Blanchard - President and Chief Executive Officer Sylvia Cheung - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti & Company, LLC Michael Petusky - Barrington Research Associates, Inc. Operator Thank you for standing by. This is the conference operator. Welcome to the Q2 2020 Anika Therapeutics Earnings Conference Call. As ...